Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : TITAN PHARMACEUTICAL (TTP) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (60)	5/17/1999 7:48:00 PM
From: Miljenko Zuanic	Read Replies (1) \| Respond to of 362

<<Anybody here believe this?>> No, not a single word! They done some preliminary pre-clinical studies in primates (reported that last year at LA neuro conference) and that's all. Here is way: <<Research and development expenses for the first quarter 1999 were increased by approximately 24% compared to the first quarter of 1998. Consistent with most recent results, the Company anticipates these expenses will continue to trend downward over the next few quarters. >> PI for Spheramine: first it was in 98, than in 99, now is in late 99, tomorow will be 00,....never end. From 98 10-K: <<Preliminary evidence of efficacy of Spheramine has been demonstrated in a validated primate model of Parkinson's Disease (MPTP monkey model). Further preclinical studies in primates are in progress and the Company plans to begin Phase I/II clinical trials of this product in Parkinson's disease during 1999.>> From last S3: <<We will need additional financing. At March 15, 1999, we had working capital of approximately $13 million which we believe will enable us to fund our operations for at least 18 months.>> To fund my ass. The best will be to force them into 2 year non-paid vocation (they can't do any damage) and wait to see what happen with Ilo. Can you image what will be their bonuses and stock options for 98? For what? Miljenko